Literature DB >> 7551117

Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient.

E O Major1, G S Ault.   

Abstract

Progressive multifocal leukoencephalopathy is a viral-induced demyelinating disease of the central nervous system usually occurring in the immunocompromised individual. The incidence of progressive multifocal leukoencephalopathy has risen sharply over the past decade because of widespread human immunodeficiency virus infection leading to immunodeficiency. This increased incidence of progressive multifocal leukoencephalopathy may also be due to better recognition of its clinical signs, and more rapid and reliable laboratory diagnosis of JC virus, the etiologic agent. There have also been advances in the molecular detection of the JC virus and the identification of variations in the viral genome sequence that may affect its multiplication cycle in different tissues. Clinical and basic research have resulted in a better understanding of the pathogenesis of progressive multifocal leukoencephalopathy and have provided sufficient information to plan new approaches for treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551117

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  17 in total

1.  Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients.

Authors:  P Ferrante; M Mediati; R Caldarelli-Stefano; L Losciale; R Mancuso; A E Cagni; R Maserati
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Authors:  J Hodel; O Outteryck; S Verclytte; V Deramecourt; A Lacour; J-P Pruvo; P Vermersch; X Leclerc
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

3.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

4.  A cell-free replication system for human polyomavirus JC DNA.

Authors:  J Nesper; R W Smith; A R Kautz; E Sock; M Wegner; F Grummt; H P Nasheuer
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

6.  Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy.

Authors:  L Monno; G B Zimatore; M Di Stefano; A Appice; P Livrea; G Angarano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

7.  Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle.

Authors:  Ilker K Sariyer; Ilhan Akan; Victoria Palermo; Jennifer Gordon; Kamel Khalili; Mahmut Safak
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Activities of various compounds against murine and primate polyomaviruses.

Authors:  G Andrei; R Snoeck; M Vandeputte; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

9.  Generation and characterization of JCV permissive hybrid cell lines.

Authors:  Ilker K Sariyer; Mahmut Safak; Jennifer Gordon; Kamel Khalili
Journal:  J Virol Methods       Date:  2009-03-04       Impact factor: 2.014

10.  Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen.

Authors:  Ilker K Sariyer; Kamel Khalili; Mahmut Safak
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.